This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC).
This activity is supported by an educational grant from the Bristol-Myers Squibb Company.
This initiative aims to provide guidance for oncologists; oncology nurse practitioners, physician assistants, nurses, and pharmacists; patient navigators, social workers, and other healthcare professionals who are involved in the care of patients with cancer in the community setting, on the practical issues related to the optimal integration of immunotherapies to treat cancer.
This program will focus on clinical evidence for optimal integration of immunotherapy agents into clinical practice. Topics covered include: monitoring for and managing immune-related adverse events, care coordination and communication between oncology and non-oncology specialists, shared decision-making, reimbursement, post-IO survivorship, and assessment of institution- or practice-specific gaps.
12:00 – 12:05 PM Welcome and Introductions
12:05 – 12:20 PM Assessment of practice patterns for optimal integration of immunotherapies
12:20 – 1:20 PM Clinical Case Presentations and Discussion
1:20 – 1:30 PM Program Evaluation, Post-activity assessment, and Question and Answers
Thai Ho, MD, PhD
Assistant Professor, Division of Hematology/Oncology
Mayo Clinic Arizona
In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and Association of Community Cancer Centers (ACCC). AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
AXIS Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AXIS Medical Education designates this continuing nursing education activity for 1.5 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
For information about the accreditation of this program please contact AXIS at firstname.lastname@example.org.
AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Name of Faculty or Presenter/Planner
Reported Financial Relationship
Thai Ho, MD, PhD
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Name of Planner/Manager/Reviewer
Latha Shivakumar, PhD
Nothing to disclose
Leigh M. Boehmer, PharmD, BCOP
Marilyn Haas, PhD, RN, CNS, ANP-BC
Dee Morgillo, MEd.,CHCP
Linda Gracie King
Robert Mocharnuk MD
Common stock: Merck
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
AXIS Medical Education affirms that the content and format of the certified activity and its related materials promote improvements and quality in healthcare and do not promote a specific proprietary business interest of a commercial entity. To this end, AXIS employs several strategies to ensure the absence of commercial bias, including, but not limited to, review of all planned content for certified activities to ensure adherence to the Accreditation Council for Continuing Medical Education’s content validation guidelines, and resolution of any actual or perceived conflicts of interest that exist.
We employ several metrics during review of content materials, including:
There is no fee for this educational activity.
To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing and returning the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be emailed to you within 3 weeks.